This mechanistic distinction is scientifically significant because it frames BPC-157 as a cytoprotection-associated research peptide rather than as an acid-suppressive compound
Possible side effects across the group include mild injection site irritation (CJC + Ipamorelin, Sermorelin, MOTS-C, IGF-1 LR3, MGF, TB-500), transient water retention (CJC + Ipamorelin), appetite changes and mild blood glucose changes especially with high carbohydrate intake (CJC + Ipamorelin), temporary fatigue or light dizziness and mild nausea (MOTS-C), headache or fatigue (IGF-1 LR3), and temporary muscle soreness (MGF)
It is advisable to start with small amounts and gradually increase to assess individual tolerance
It may therefore not be surprising that important modulators of the glucose homeostasis, including glucagon and insulin, have been proven to be functionally relevant in TBC